FDA Approves Cordis’ Vascular Closure Device for Cardiac Ablation Procedures

No Comments

Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures.

Leave a Reply

Your email address will not be published. Required fields are marked *